講演情報
[4O09m-2-1]ミクログリアは免疫チェックポイント分子 Tim3を介してアミロイドβ病理を制御する
*木村 公俊1,2,3,4、Ayshwarya Subramanian1,2,3,5、Zhuoran Yin1,2,3,6、Ahad Khalilnezhad1,2,3,5、Yufan Wu1,2,3,5、Danyang He1,2,3、Dennis Selkoe1,2,3、Aviv Regev5、Mario Suvà5,7、Oleg Butovsky1,2,3、Vijay Kuchroo1,2,3,5 (1. The Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Mass General Hospital and Harvard Medical School, Boston, MA, USA.、2. Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.、3. Department of Neurology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA.、4. 京都大学大学院医学研究科 臨床神経学、5. Broad Institute of MIT and Harvard, Cambridge, MA, USA.、6. Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.、7. Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.)
キーワード:
microglia、Tim3、Alzheimer's disease、MGnD
閲覧にはパスワードが必要です
コメント
コメントの閲覧・投稿にはログインが必要です。ログイン